In recent years, the emerging optical imaging technologies have shown their unique value in diagnosis of disease and surgical navigation. This article focus on describing the optical imaging technology mediated by the only one near-infrared light imaging molecule--indocyanine green which has already been approved by FDA to use in clinical and inmates a characteristics of passive targeting liver cancer tissue. This article reviews the application of the technology in liver cancer surgery and demonstrates the value, deficiency and possible improvements of this technology.